Why the study?
Hypertension and age-related dementia are increasing in Asian elderly populations, prompting a review of blood pressure treatments and optimal targets relating to cognitive outcomes.
Does blood pressure management prevent dementia in elderly hypertensive patients?
Does blood pressure management prevent dementia in elderly hypertensive patients?
Maintaining systolic blood pressure at 120-130 mmHg and regulating the renin-angiotensin system may help prevent dementia in elderly hypertensive patients.
Supports SBP 120-130 mm Hg and RAS modulation for dementia prevention in elderly hypertensives; leaves open confirmation by randomized trials.
Hypertension is a significant public health apprehension. The commonness keeps rising, and it is a risk issue for a number of unfavorable health outcomes counting a refuse in cognitive utility. The commonness of hypertension and age-related dementia is increasing in Asian countries, within the aged grouping. This review aims to talk about potential treatments for high blood pressure in the aged and suggest a most favorable objective for BP relation to cognitive results. Our review discusses a number of studies on associated blood pressure treatments to stay contentious and the penalty if the action aim is also low or violent. Longitudinal and cross-sectional, studies were incorporated in this appraisal. A most favorable systolic blood pressure of 120-130 mm Hg is not compulsory, particularly in no diabetic hypertensive patients with significant risk factors. The renin-angiotensin scheme (RAS) is extremely occupied in not only hypertension other than also lifestyle-related diseases, and might contribute to the pathological mechanism in dementia; consequently, RAS instruction is anticipated to stop dementia.
No takes yet. Share an insight, caveat, or question.
E. D. Sipahi (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: